Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 859.85 INR 1.24%
Market Cap: 357.2B INR
Have any thoughts about
Ajanta Pharma Ltd?
Write Note

Ajanta Pharma Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ajanta Pharma Ltd
Long-Term Investments Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Ajanta Pharma Ltd
NSE:AJANTPHARM
Long-Term Investments
â‚ą340m
CAGR 3-Years
-12%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Long-Term Investments
â‚ą6.5B
CAGR 3-Years
-11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Investments
â‚ą12.2B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
13%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Investments
â‚ą68.1B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
23%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Investments
â‚ą650m
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Investments
â‚ą3.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ajanta Pharma Ltd's Long-Term Investments?
Long-Term Investments
340m INR

Based on the financial report for Sep 30, 2024, Ajanta Pharma Ltd's Long-Term Investments amounts to 340m INR.

What is Ajanta Pharma Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
18%

Over the last year, the Long-Term Investments growth was -6%. The average annual Long-Term Investments growth rates for Ajanta Pharma Ltd have been -12% over the past three years , 18% over the past five years .

Back to Top